Related Experiment Video
Updated: Jul 7, 2025

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
Intestinal injury in paracetamol overdose (ATOM-8)
Varan Perananthan1,2, Fathima Shihana1,2, Angela L Chiew2,3,4
1Edith Collins Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
Paracetamol overdose causes intestinal toxicity, indicated by elevated intestinal fatty acid binding protein (IFABP). This toxicity may explain early hyperlactatemia and impacts drug absorption and liver damage.
Area of Science:
- Toxicology
- Gastroenterology
- Pharmacology
Background:
- Paracetamol (acetaminophen) overdose is known for liver damage.
- Intestinal toxicity from high paracetamol levels during absorption is less understood.
- This study investigates paracetamol-induced intestinal injury.
Purpose of the Study:
- To determine if paracetamol overdose causes intestinal toxicity.
- To correlate intestinal damage markers with early and late paracetamol toxicity.
- To explore the link between intestinal toxicity and hyperlactatemia.
Main Methods:
- Analyzed plasma intestinal fatty acid binding protein (IFABP) and gut microRNAs in 30 overdose patients.
- Measured markers of enterocyte damage.
- Performed sub-analysis on patients with early hyperlactatemia (lactate > 2 mmol/L within 12h).
Main Results:
- Plasma IFABP was significantly elevated in paracetamol overdose patients versus controls.
- Patients with early hyperlactatemia showed higher IFABP levels.
- IFABP correlated with paracetamol and lactate concentrations; miR-122 and miR-215 were downregulated in early hyperlactatemia.
Conclusions:
- Paracetamol overdose induces concentration-dependent intestinal toxicity.
- Intestinal toxicity may explain early hyperlactatemia syndrome.
- Intestinal toxicity could affect drug absorption and hepatotoxicity progression.
Related Concept Videos
Prevention of Further Absorption of Poison
Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Esophageal Perforation-I: Introduction
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:

